Overview
Primary liver cell carcinoma (PLC) can present with portal vein tumor thrombus (PVTT), significantly impacting prognosis and treatment strategies.Diagnosis
Imaging studies (CT, MRI) essential for detecting PVTT 12
Contrast-enhanced imaging helps assess thrombus extent and portal vein patency 1
Laboratory tests including AFP and tumor markers for PLC staging 1Management
First-line treatments:
- Percutaneous endovascular radiofrequency ablation (RFA) for PVTT 1
- Transcatheter arterial chemoembolization (TACE) as an alternative or adjunct 1
Adjunctive therapies:
- Laser ablation for PVTT, often combined with chemotherapy drugs like mitomycin C (MMC) and fluorouracil (5-Fu) 2
- Three-dimensional conformal radiotherapy (3D CRT) as an alternative to laser ablation 2Special Populations
No specific data provided in abstracts regarding pregnancy, pediatrics, elderly, or comorbidities in the context of PVTT treatment 12Key Recommendations
Percutaneous endovascular radiofrequency ablation (RFA) significantly improves effective treatment rates and survival compared to sequential TACE for PVTT associated with PLC (Evidence: Moderate) 1
Laser ablation shows higher overall remission rates and fewer postoperative complications compared to radiotherapy for PVTT management (Evidence: Moderate) 2
Consider combining ablation techniques with targeted chemotherapy agents like MMC and 5-Fu to enhance efficacy (Evidence: Weak) 2References
1 Kong YL, Sun JJ, Zhang HY, Xing Y, Wang C, Liu Y et al.. Clinical evaluation of percutaneous endovascular radiofrequency ablation for portal vein tumor thrombus: experience in 120 patients. Surgical endoscopy 2023. link
2 Sun B, Luo M, Lu Z, Meng Y, Wu S, Wu M. Clinical studies of laser ablation in treatment of primary liver carcinoma-associated portal vein tumor thrombus. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2010. link